0415SP |
Chlorophacinone (Qualitative), Serum/Plasma |
0921SP |
Cadmium, Serum/Plasma |
0921TI |
Cadmium, Tissue |
0921U |
Cadmium, Urine |
0950SP |
Camphor, Serum/Plasma |
0980SP |
Carbaryl and Metabolite, Serum/Plasma |
0995U |
Carbon Disulfide Exposure (TTCA), Urine |
1006TI |
Carbon Monoxide - Iron Ratio Profile, Tissue |
1042SP |
Cesium, Serum/Plasma |
1042U |
Cesium, Urine |
1070SP |
Chlordane and Metabolites, Serum/Plasma |
1110SP |
Chlorobenzene, Serum/Plasma |
1111U |
Chlorobenzene Exposure (p-Chlorophenol), Urine |
1261SP |
Chromium, Serum/Plasma |
1261TI |
Chromium, Tissue |
1261U |
Chromium, Urine |
1265SP |
Chromium and Cobalt, Serum/Plasma |
1265U |
Chromium and Cobalt, Urine |
1290SP |
Cobalt, Serum/Plasma |
1290TI |
Cobalt, Tissue |
1290U |
Cobalt, Urine |
1330SP |
Copper, Serum/Plasma |
1330TI |
Copper, Tissue |
1330U |
Copper, Urine |
1348U |
Creatinine, Urine Overview: Evaluate Extent of Urine Dilution or Concentration |
1409SP |
Cyclohexanone, Serum/Plasma |
1409U |
Cyclohexanone, Urine |
1410U |
Cyclohexanol, Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |